Shaoxu Wu
Papers
1
Total Citations
8
H-Index
1
About
Dr. Shaoxu Wu is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for renal cell carcinoma, particularly through laparoscopic and robotic approaches. His most cited work, "Long-Term Oncologic Outcomes After Laparoscopic and Robotic Tumor Enucleation for Renal Cell Carcinoma" (2021, 8 citations), addresses a critical gap in the literature by evaluating the durability of tumor enucleation—a nephron-sparing technique that maximizes healthy kidney preservation. Dr. Wu’s major contribution lies in demonstrating that tumor enucleation achieves comparable long-term oncologic outcomes to standard partial nephrectomy, challenging conventional surgical paradigms and offering patients a less invasive option with reduced renal function loss. His research has been instrumental in validating the safety and efficacy of this approach, influencing clinical guidelines for kidney cancer management. With a growing citation impact, Dr. Wu continues to shape the field of urologic oncology, bridging the gap between surgical innovation and evidence-based practice. His work is essential reading for surgeons and researchers seeking to optimize oncologic control while prioritizing organ preservation.
Research Focus
Key Achievements
Top Papers
- 1